Meta Health Limited
Catalist:5DX 株式レポート
Meta Health 将来の成長 現在、 Meta Healthの成長と収益を予測するのに十分なアナリストの調査がありません。
主要情報 Machinery 収益成長 37.6% 収益成長率 n/a 将来の株主資本利益率 n/a アナリストカバレッジ None
最終更新日 n/a
今後の成長に関する最新情報
Meta Health Limited Provides Financial Guidance for the First Half Year Ended June 30, 2022 Jul 19
Metal Component Engineering Limited Provides Group Earnings Guidance for the Half Year Ended 30 June 2020 Aug 02
すべての更新を表示
First half 2024 earnings released: EPS: S$0 (vs S$0.004 loss in 1H 2023) Aug 10
New major risk - Share price stability May 03
Meta Health Limited Announces the Appointment of Cheah You Kong as the Acting Head of Finance and as an Executive Officer, Effective May 1, 2024 Apr 19
Meta Health Limited, Annual General Meeting, Apr 29, 2024 Apr 13
High number of new directors Apr 08
Meta Health Limited Announces Resignation of Tan Sze Leng as Chief Financial Officer, Effective from 17 May 2024 Mar 05
New major risk - Negative shareholders equity Mar 02
Full year 2023 earnings released: S$0.004 loss per share (vs S$0.016 loss in FY 2022) Mar 02
New minor risk - Financial data availability Feb 20
Meta Health Limited Announces the Cessation of Mr. Chua Kheng Choon as Senior Vice President of Engineering Jan 05
High number of new and inexperienced directors Dec 01
New major risk - Shareholder dilution Nov 05
High number of new and inexperienced directors Nov 01
Meta Health Limited Appoints Lim Qing Ru as Independent Non-Executive Director, Member of the Audit Committee, the Nominating Committee and the Remuneration Committee, Effective from 1 November 2023 Oct 23
New major risk - Share price stability Aug 11
New major risk - Revenue and earnings growth Aug 07
First half 2023 earnings released: S$0.004 loss per share (vs S$0.005 loss in 1H 2022) Aug 07
New major risk - Share price stability Jun 27
Full year 2022 earnings released: S$0.013 loss per share (vs S$0.018 profit in FY 2021) Mar 03
Meta Health Limited to Report Fiscal Year 2022 Results on Mar 01, 2023 Feb 01 Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effect from 12 December 2022
Executive Chairman & Group CEO recently bought S$59k worth of stock Sep 27
Meta Health Limited Appoints Tan Sze Leng as Chief Financial Officer, Effective from 21 September 2022 Aug 20
Executive Chairman & Group CEO recently bought S$59k worth of stock Aug 17
First half 2022 earnings released Aug 14
Meta Health Limited Provides Financial Guidance for the First Half Year Ended June 30, 2022 Jul 19
High number of new and inexperienced directors Jul 02
Meta Health Limited Announces Appointment of Law Ren Kai Kenneth as Independent Non-Executive Director, Chairman of the Audit Committee, and A Member of the Nominating Committee and the Remuneration Committee Jun 25 Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effective 12 December 2022
Meta Health Limited Announces Resignation Leow Siew Yon, Cynthia as Independent Non-Executive Director, Chairman of the Nominating Committee, and a Member of the Audit Committee and the Remuneration Committee Jun 11 Meta Health Limited Announces Management Changes
Full year 2021 earnings released: EPS: S$0.018 (vs S$0.005 loss in FY 2020) Apr 16
Meta Health Limited, Annual General Meeting, Apr 28, 2022 Apr 14
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 03
Now 23% undervalued after recent price drop Jan 18
Metal Precision Services Pte Ltd. completed the acquisition of 85.07% stake in Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian. Jul 15
Metal Component Engineering Limited (Catalist:5DX) agreed to acquire Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian for SGD 11.1 million. Jun 09
Metal Component Engineering Considers Potential Acquisition Jun 08
Independent Non-Executive Director has left the company May 07
Full year 2020 earnings released Feb 28
Metal Component Engineering Limited Announces Board Changes, Effective January 1, 2021 Jan 01
Metal Component Engineering Limited Provides Group Earnings Guidance for the Half Year Ended 30 June 2020 Aug 02
Metal Component Engineering Limited to Report First Half, 2020 Results on Aug 14, 2020 Jul 31
このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Meta Health は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。
シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。
業績と収益の成長予測 Catalist:5DX - アナリストの将来予測と過去の財務データ ( )SGD Millions 日付 収益 収益 フリー・キャッシュフロー 営業活動によるキャッシュ 平均アナリスト数 6/30/2024 1 -2 -3 -2 N/A 3/31/2024 3 -3 -3 -2 N/A 12/31/2023 5 -3 -3 -2 N/A 6/30/2023 -4 -6 -2 -2 N/A 3/31/2023 4 -7 -2 -2 N/A 12/31/2022 11 -7 -3 -2 N/A 9/30/2022 38 -5 -3 -3 N/A 6/30/2022 42 -2 -3 -3 N/A 3/31/2022 42 0 -2 -1 N/A 12/31/2021 43 1 0 0 N/A 9/30/2021 41 4 1 2 N/A 6/30/2021 39 0 3 3 N/A 3/31/2021 35 -1 1 2 N/A 12/31/2020 32 -2 0 0 N/A 9/30/2020 34 -2 1 2 N/A 6/30/2020 36 -2 2 3 N/A 3/31/2020 41 -1 3 5 N/A 12/31/2019 45 0 4 6 N/A 9/30/2019 46 -1 2 4 N/A 6/30/2019 46 -3 0 2 N/A 3/31/2019 47 -4 -1 0 N/A 12/31/2018 47 -5 -3 -1 N/A 9/30/2018 49 -6 -4 -2 N/A 6/30/2018 51 -6 -6 -3 N/A 3/31/2018 53 -7 N/A -2 N/A 12/31/2017 56 -9 N/A 0 N/A 9/30/2017 58 -8 N/A 2 N/A 6/30/2017 61 -6 N/A 4 N/A 3/31/2017 57 -4 N/A 3 N/A 12/31/2016 53 -2 N/A 2 N/A 6/30/2016 47 1 N/A 2 N/A 3/31/2016 50 1 N/A 5 N/A 12/31/2015 52 1 N/A 7 N/A 9/30/2015 60 0 N/A 6 N/A 6/30/2015 61 -1 N/A 5 N/A 3/31/2015 65 -2 N/A 2 N/A 12/31/2014 69 -3 N/A 0 N/A 9/30/2014 70 -3 N/A 2 N/A 6/30/2014 71 -2 N/A 5 N/A 3/31/2014 70 -1 N/A 5 N/A 12/31/2013 69 0 N/A 5 N/A
もっと見る
アナリストによる今後の成長予測
収入対貯蓄率: 5DXの予測収益成長が 貯蓄率 ( 2.2% ) を上回っているかどうかを判断するにはデータが不十分です。
収益対市場: 5DXの収益がSG市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です
高成長収益: 5DXの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。
収益対市場: 5DXの収益がSG市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。
高い収益成長: 5DXの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。
将来の株主資本利益率
将来のROE: 5DXの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です
Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}